1. The Long-Acting Phosphodiesterase Inhibitor Tadalafil does not Influence Athletes' V·O2max, Aerobic, and Anaerobic Thresholds in Normoxia
- Author
-
Andrea Lenzi, L. Di Luigi, Fabio Pigozzi, Laura Guidetti, Ferdinando Iellamo, Gian Pietro Emerenziani, Mc Gallotta, Emanuela Ciminelli, Paolo Sgrò, Carlo Baldari, and Francesco Romanelli
- Subjects
Male ,systolic blood pressure ,double blind procedure ,Settore MED/09 - Medicina Interna ,Anaerobic Threshold ,Phosphodiesterase Inhibitors ,Settore MED/13 - Endocrinologia ,Tadalafil ,human experiment ,Placebos ,lung gas exchange ,chemistry.chemical_compound ,heart rate ,Orthopedics and Sports Medicine ,lactate blood level ,Respiratory exchange ratio ,Cross-Over Studies ,article ,clinical trial ,aerobic exercise ,Italy ,bicycle ergometer ,Cardiology ,athlete ,arterial pressure ,headache ,Anaerobic exercise ,medicine.drug ,Adult ,medicine.medical_specialty ,crossover procedure ,Sildenafil ,lactic acid ,placebo ,tadalafil ,adult ,anaerobic exercise ,controlled clinical trial ,controlled study ,exercise tolerance ,heart hemodynamics ,human ,male ,oxygen consumption ,Carbolines ,Delayed-Action Preparations ,Double-Blind Method ,Exercise Test ,Humans ,Oxygen Consumption ,Physical Endurance ,Oxygen pulse ,Physical Therapy, Sports Therapy and Rehabilitation ,Physical exercise ,Placebo ,Internal medicine ,medicine ,business.industry ,Endocrinology ,Blood pressure ,chemistry ,business - Abstract
Whereas experimental studies showed that in healthy trained subjects, the phosphodiesterase-5 inhibitor (PDE-5i) sildenafil improves exercise capacity in hypoxia and not in normoxia, no studies on the effects of the long half-life PDE-5i tadalafil exist. In order to evaluate whether tadalafil influences functional parameters and performance during a maximal exercise test in normoxia, we studied 14 healthy male athletes in a double-blind cross-over protocol. Each athlete performed two tests on a cycle ergometer, both after placebo or tadalafil (at therapeutic dose: 20 mg) administration. Oxygen consumption (VO2), blood lactate, respiratory exchange ratio, rate of perceived exertion, arterial blood pressure (BP), heart frequency (HR) and oxygen pulse (VO2/HR) were evaluated before exercise, at individual ventilatory and anaerobic thresholds (IVT and IAT), at VO2max and during recovery. Compared to placebo, a single tadalafil administration significantly reduced systolic BP before and after exercise (p < 0.05), decreased VO2/HR at IVT (13.3 +/- 1.8 vs. 14.5 +/- 2.1 mL . beat (-1); p = 0.03), but did not modify individual VO2max, IVT, or IAT. In healthy athletes, 20 mg of tadalafil does not substantially influence physical fitness-related parameters, exercise tolerance, and cardiopulmonary responses to maximal exercise in normoxia; it remains to be verified if higher doses/prolonged use influence health and/or sport performance in field conditions.
- Published
- 2008
- Full Text
- View/download PDF